Crinetics Pharmaceuticals, Inc.

CRNXDelisted Sep 1, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001658247

SEC filings (opens in a new tab)

Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.

Q2 2024 vs. Q1 2024

How the institutions holding Crinetics Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of CRNX: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	203	1	234	+32
Shares	80.4M	60.3K	82.5M	+2.12M (+2.6%)
Value	$3.76B	$2.82M	$3.69B	−$65.9M (−1.8%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (48)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CRNX in Q2 2024
Institution	Shares	Value	% of portfolio
Hood River Capital Management LLC	410,342	$18.4M	0.38%
First Turn Management, LLC	369,302	$16.5M	2.69%
Maplelane Capital, LLC	160,000	$7.17M	0.54%
Marshall Wace, LLP	141,204	$6.32M	0.01%
Senator Investment Group LP	135,000	$6.05M	0.29%
Man Group plc	125,714	$5.63M	0.01%
Balyasny Asset Management LLC	114,637	$5.13M	0.01%
Baker Bros. Advisors LP	103,927	$4.65M	0.06%
ADAR1 Capital Management, LLC	74,850	$3.35M	0.68%
Nicholas Investment Partners, LP	53,012	$2.37M	0.25%
Corebridge Financial, Inc.	41,863	$1.88M	0.01%
Mirae Asset Global ETFs Holdings Ltd.	38,390	$1.71M	0.00%
Twinbeech Capital LP	30,631	$1.37M	0.03%
Engineers Gate Manager LP	25,282	$1.13M	0.03%
Ameriprise Financial Inc	24,798	$1.11M	0.00%
Trexquant Investment LP	22,538	$1.01M	0.02%
Connor, Clark & Lunn Investment Management Ltd.	20,128	$901.5K	0.00%
Gilder Gagnon Howe & Co LLC	12,836	$574.9K	0.01%
Lewis Asset Management, LLC	12,395	$555.2K	0.42%
Alpine Global Management, LLC	11,317	$506.9K	0.09%
Cresset Asset Management, LLC	9,062	$405.9K	0.00%
Occudo Quantitative Strategies LP	8,561	$383.4K	0.07%
Taikang Asset Management (Hong Kong) Co Ltd	8,500	$380.7K	0.06%
Knott David M Jr	8,426	$377.0K	0.15%
PEAK6 Investments LLC	8,000	$358.3K	0.02%
Sectoral Asset Management Inc	5,800	$259.8K	0.11%
Atria Wealth Solutions, Inc.	5,497	$246.2K	0.00%
Kestra Advisory Services, LLC	5,083	$227.7K	0.00%
Xponance, Inc.	4,930	$220.8K	0.00%
Dynamic Technology Lab Private Ltd	4,919	$220.0K	0.02%
Harbour Capital Advisors, LLC	4,550	$209.6K	0.05%
Baird Financial Group, Inc.	4,470	$200.2K	0.00%
EntryPoint Capital, LLC	2,845	$127.4K	0.06%
Advisors Asset Management, Inc.	1,798	$80.5K	0.00%
CIBC Private Wealth Group, LLC	934	$42.4K	0.00%
Quest Partners LLC	934	$41.8K	0.01%
Global Retirement Partners, LLC	259	$11.6K	0.00%
Bessemer Group Inc	192	$9.00K	0.00%
Farmers & Merchants Investments Inc	200	$8.96K	0.00%
Clearstead Advisors, LLC	182	$8.15K	0.00%
Smartleaf Asset Management LLC	132	$5.74K	0.00%
Ashton Thomas Private Wealth, LLC	80	$3.58K	0.00%
Innealta Capital, LLC	36	$1.61K	0.00%
Massmutual Trust Co FSB	34	$1.52K	0.00%
GWM Advisors LLC	30	$1.34K	0.00%
Householder Group Estate & Retirement Specialist, LLC	25	$1.00K	0.00%
Bell Investment Advisors, Inc	15	$672	0.00%
CWM, LLC	11	$0	0.00%

Sold out (16)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of CRNX in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Vivo Capital, LLC	350,000	$16.4M
Opaleye Management Inc.	210,000	$9.83M
Woodline Partners LP	153,395	$7.18M
Silverarc Capital Management, LLC	127,835	$5.98M
Candriam Luxembourg S.C.A.	88,005	$4.12M
American International Group, Inc.	32,509	$1.52M
Omers Administration Corp	11,100	$519.6K
Two Sigma Securities, LLC	7,841	$367.0K
Aquatic Capital Management LLC	7,100	$332.4K
Atom Investors LP	4,887	$228.8K
Oppenheimer Asset Management Inc.	4,276	$200.2K
Metropolitan Life Insurance Co	3,573	$167.3K
Amundi	3,352	$144.2K
Belvedere Trading LLC	2,114	$99.0K
Catalyst Funds Management Pty Ltd	1,000	$46.8K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	245	$11.5K

Not filed for Q2 2024 yet (1)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRNX in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	60,287	$2.82M